Cristian Luput, Director at MAIA Biotechnology, Inc. (MAIA), bought 1,576 shares at $3.69 ($6K) on 2023-04-17, disclosed to the SEC on 2023-04-18.
Scheduled purchase ($6k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MAIA | BUY | 2024-11-04 | $111K | — | Filing → |
| MAIA | BUY | 2024-03-15 | $162K | — | Filing → |
| MAIA | BUY | 2023-05-17 | $8K | — | Filing → |